Sugi Predict

Sugi Predict / Compounds / SCHEMBL4201683

SCHEMBL4201683

SCHEMBL4201683

COc1ccc(NS(=O)(=O)c2cc(Cl)c(Cl)s2)c2c1C[C@@H](N(C)C)CO2

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 1/20 0.45
▸ QRFPR Q96P65 1/20 0.45
▸ PTGES2 Q9H7Z7 1/20 0.39
▸ CCR4 P51679 2/20 0.37
▸ MAPK1 P28482 2/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ ACLY P53396 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ CCR1 P32246 1/20 0.34
▸ CCR2 P41597 1/20 0.34
▸ GHSR Q92847 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4215742 0.91 HTR6 (0.44) HTR6QRFPRMAPK1HTR7POLB
SCHEMBL4209408 0.87 SMN1; SMN2 (0.47) HTR6QRFPRPTGES2CCR4MAPK1
SCHEMBL4208341 0.85 HTR6 (0.41) HTR6QRFPRMAPK1HTR7POLB
SCHEMBL4210926 0.85 HTR6 (0.49) HTR6QRFPRMAPK1HTR7ACLY
SCHEMBL4199409 0.84 HTR6 (0.49) HTR6QRFPRHTR7ACLY
SCHEMBL4211763 0.83 HTR6 (0.46) HTR6QRFPRMAPK1GHSRALDH1A1
SCHEMBL4204580 0.83 MAPK1 (0.53) HTR6QRFPRMAPK1HTR7POLB
SCHEMBL4205702 0.83 HTR6 (0.46) HTR6QRFPRCCR4HTR7GHSR
SCHEMBL4202462 0.83 HTR6 (0.50) HTR6QRFPRMAPK1HTR7ACLY
SCHEMBL4196391 0.83 HTR6 (0.44) HTR6QRFPRCCR4MAPK1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090030038-A1 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor ASTRAZENECA AB (SE) 2009-01-29 — — US claimed
EP-1888517-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR AstraZeneca AB (SE) 2008-02-20 — — EP claimed
WO-2006126939-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR ASTRAZENECA AB (SE) 2006-11-30 — — WO claimed
US-20090030038-A1 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor ASTRAZENECA AB (SE) 2009-01-29 — — US disclosed
EP-1888517-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR AstraZeneca AB (SE) 2008-02-20 — — EP disclosed
WO-2006126939-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR ASTRAZENECA AB (SE) 2006-11-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030038-A1 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor HTR6, HTR1A, HTR1D HTR6 1/4885QRFPR 81/4885PTGES2 1510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.